Showcases Stock ranks Forex

Abbvie Inc (ABBV)
104.89  0.69 (0.66%) 11-27 13:02
Open: 104.98 Pre. Close: 104.2
High: 105.8 Low: 104.3
Volume: 4,346,686 Market Cap: 185,113M
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Jacobio Pharmaceuticals; I-Mab; and Genmab A/S. The company was incorporated in 2012 and is based in North Chicago, Illinois.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 104.523 - 104.832 104.832 - 105.178
Low: 102.436 - 102.819 102.819 - 103.248
Close: 103.526 - 104.103 104.103 - 104.749
Stock Technical Analysis
Target: Six months: 123.57
One year: 144.33
Support: Support1: 89.31
Support2: 79.11
Resistance: Resistance1: 105.80
Resistance2: 123.57
Pivot: 99.58
Moving Averages: MA(5): 103.21
MA(20): 97.16
MA(100): 92.64
MA(250): 89.41
MACD: MACD(12,26): 4.15
Signal(12,26,9): 3.49
%K %D: %K(14,3): 94.08
%D(3): 94.51
RSI: RSI(14): 77.04
52-Week: High: 105.8
Low: 62.55
Change(%): 20.5
Average Vol(K): 3-Month: 823130
10-Days: 807853
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.

ABBV has closed below upper band by 8.2%. Bollinger Bands are 55.5% wider than normal. The large width of the bands suggest high volatility as compared to ABBV's normal range. The bands have been in this wide range for 16 bars. This is a sign that the current trend might continue.
Stock chart
Stock News
Fri, 27 Nov 2020
Reasons Why Long-term Faith on AbbVie Inc. (ABBV) Could Pay Off Investors - The InvestChronicle

Wed, 25 Nov 2020
How is Abbvie Inc (NYSE: ABBV) Preparing For Life After Humira? - Yahoo Finance

Wed, 25 Nov 2020
We Analyzed the Future Direction of AbbVie Inc. (ABBV), Here is What We Found - The News Heater

Mon, 23 Nov 2020
AbbVie Inc. (ABBV) recently have taken one step ahead with the beta value of 0.76 - News Daemon

Mon, 23 Nov 2020
AbbVie Inc. (ABBV) Profit Margins posted 18.00% in the last twelve months: The key fundamentals to watch - The InvestChronicle

Thu, 19 Nov 2020
AbbVie Inc. (ABBV) Presents at Wolfe Research Healthcare Conference (Transcript) - Seeking Alpha

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 1760.00
Shares Float (M) 1760.00
% Held by Insiders 0.10
% Held by Institutions 69.98
Shares Short (K) 12840
Shares Short Prior Month (K) 12940
Stock Financials
EPS 4.570
Book Value (p.s.) 8.650
Profit Margin 18.16
Operating Margin 33.11
Return on Assets (ttm) 8.1
Return on Equity (ttm) 209.1
Qtrly Rev. Growth 52.2
Gross Profit (p.s.) 14.676
Sales Per Share 23.097
EBITDA (p.s.) 10.438
Qtrly Earnings Growth 22.50
Operating Cash Flow (M) 16010.00
Levered Free Cash Flow (M) 13840.00
Stock Valuation
PE Ratio 22.95
PEG Ratio
Price to Book value 12.13
Price to Sales 4.54
Price to Cash Flow 11.53
Stock Dividends
Dividend 4.720
Dividend Yield 0.04
Dividend Growth 5.200

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator